Mohammed I. El-Gamal, Ph.D. got his B.Sc. degree in pharmaceutical Sciences at the Faculty of Pharmacy, University of Mansoura, Egypt in 2003 with "Excellent with honor" grade, first achiever. Then he received his M.Sc. degree in medicinal chemistry from the same college. He got his Ph.D. degree in medicinal chemistry in August 2012 from Korea University of Science and Technology, Korea Institute of Science and Technology (KIST), Republic of Korea. After that, he worked as a star postdoctoral fellow at KIST and assistant professor of medicinal chemistry at the Faculty of Pharmacy, University of Mansoura, Egypt. Mohammed I. El-Gamal, Ph.D. is the author of more than 55 publications in highly reputed international peer-reviewed journals. He got 3 patents, and presented more than 38 posters and 8 oral presentations in many international conferences in The Republic of Korea, United Arab Emirates, USA, Japan, The Netherlands, and Austria. He has peer-review more than 67 articles. And he has been an editorial board member in more than 22 international journals. He has been also a member of the Asian Council of Science Editors (ACSE). Mohammed I. El-Gamal, Ph.D. and his group have developed a new more efficient prodrug of Olmesartan (antihypertensive agent) which has been marketed in the Republic of Korea. And he is interested in anticancer, antiinflammatory, and antimicrobial drug development.

Mohammed I El-Gamal Research Interests are Anticancer agents; Antiinflammatory agents; Antihypertensive Agents; Antimicrobial agents; Drug Design and Synthesis; Pharmacodynamics; Pharmacokinetics.